Business Process Outsourcing

PRODUCTS

  • Get from kickoff to first batch-run in days, not months.

    Accelerate process design without any code
    Put power in the hands of your team. With intuitive, no-code procedure and recipe authoring designed for process scientists and process engineers, your teams can configure Tempo without code.

  • Ray-tracing methods use discrete rays to represent advancing wavefronts as they propagate from a transmitter through a scene. Rays interact with geometry in the scene through reflections, diffractions, and transmissions. The two dominant ray-tracing methods are Shooting-and-Bouncing Rays and Image Theory. Remcom’s software combines these two methods to leverage the advantages of each.

  • The Center for Breakthrough Medicine (CBM) provides Analytical Development and Testing including analytical method development, method transfers, qualification and validation services. Our approach encompasses the FDA domains of safety, potency, purity, stability, and identity throughout product development and manufacturing, with the ultimate goal of safeguarding patients.

  • The MIRO ALTITUDE from Gentec-EO is a touchscreen display device for power and energy measurement using single-channel, multiple outputs (USB, Ethernet, analog).

  • Cryoport Systems’ highly anticipated Global Supply Chain Centers have been operational for a few months, and customers continue to move biopharmaceutical materials into our Houston, Texas and Morris Plains, New Jersey facilities in order to mitigate risks.

WHITE PAPERS AND CASE STUDIES

  • Advancing Cell And Gene Therapy Clinical Development In 2023

    Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.

  • UW Carbone Cancer Center Gains Visibility Into Site Accrual

    Monitoring accrual is a key responsibility for a cancer center administrator. From answering questions for leadership to preparing for a grant submission, knowing the ins and outs of a site’s accrual metrics can ensure greater operational efficiencies center-wide. Read how UWCCC was able to enhance their data analytics and visualization capabilities helping them improve operational oversight, especially through greater visibility into site accrual metrics.

  • Digital Endpoint Resource Guide: Heart Failure

    Unearth the ways actigraphy can objectively measure treatment effects on a variable that drives patient outcomes and prepare trials to better align with the FDA’s position on patient-centric drug development.

  • Implementing A Unified Lab Management Solution

    A biotech company managing several different LIMS and ELN systems saw increased workflow efficiency, better data quality, and improved decision making with a software solution.

  • Naylor Automates Preventative Maintenance And Increases Service Visibility

    Data entry was slowing down the service process for Naylor, a commercial and industrial HVAC company based out of Oakville, Ontario, as every step of delivering service required manual data input. Work orders from their contracts had to be manually prepared each month, technicians had to fill out paperwork and fax it back to the office where a data entry team would put the data into their system, and invoices had to be manually checked to ensure the proper hours and billing information was attached.

  • The Rise Of Hybrid Trials

    In this paper, we’ll define what a hybrid trial is, how it utilizes decentralized technologies and the reason for mainstream adoption of hybrid clinical trials.

  • Addressing Common Challenges In Rare Disease

    Although each rare disease is unique, many challenges to the clinical operations required for successful rare disease trials are consistent across indications. Learn more about these common challenges expected during the course of researching rare diseases that must be addressed before progressing to clinical trials.

  • An Approach To Proactive Improvement In Established QC Lab Processes

    Proactively uncovering issues and resolving human errors to avoid defects is a priority. Learn about a reliable, systematic, data-gathering approach that helps build efficiencies and future-proof processes.

  • Pacira Optimizes Manufacturing Process For Maximum Production Throughput

    Being unable to garner insights from the data for impactful decisions drove this emerging specialty pharmaceutical company to seek a solution that could accelerate data aggregation, modeling and prediction.

  • Managing Complex Global Drug Distribution And Expiry

    A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced. 

  • Conquering Business Hurdles In Personalized Cancer Immunotherapies

    Personalized immunotherapies require an innovative commercialization model that is nimble and agile enough to respond to the individualized nature of patient populations, competition, and evolving interactions with the FDA.

  • SMARTtill Solves Disappearing Cash Problem at Gainfort Stores

    Gainfort Ltd. operates two convenience stores in Huntingdon, U.K., about 70 miles north of London. At the end of employee shifts, owner Sunil Lahal noticed a disturbing trend during cash counts: The totals were off.

NEWS

  • Biosynex And Chembio Diagnostics Announce Definitive Acquisition Agreement
    1/31/2023

    Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc. (“Chembio”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the companies have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio for $0.45 per share, representing a premium of 27% compared to the closing price of Chembio stock on January 30, 2023, in an all-cash transaction valued at $17.2 million.

  • Shift And CarLotz Agree To Merge, Creating A Differentiated Used Auto Ecommerce Retailer
    8/9/2022

    Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars, and CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, announced today that they have entered into a definitive agreement to combine in a stock-for-stock merger. The combined company will continue to trade on Nasdaq under the ticker SFT.

  • Vivos Therapeutics Receives FDA 510(K) Clearance Of Its Flagship DNA Oral Appliance For Treatment Of Obstructive Sleep Apnea
    1/4/2023

    Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, today announced a brand new clearance from the U.S. Food and Drug Administration (FDA) for its proprietary DNA appliance (daytime-nighttime appliance).

  • New Imaging Technique Could Speed Up Development Of Eye Disease Treatments
    9/29/2022

    Researchers have developed a simple and fast way to perform optoretinography, an imaging technique that measures light-induced functional activity in the eye’s retina, the network of neurons in the back of our eyes responsible for detecting light and initiating vision.

  • New Chip-Based Beam Steering Device Lays Groundwork For Smaller, Cheaper Lidar
    8/4/2022

    Researchers have developed a new chip-based OPA that solves many of the problems that have plagued OPAs. They show that the device can eliminate a key optical artifact known as aliasing, achieving beam steering over a large field of view while maintaining high beam quality, a combination that could greatly improve lidar systems.